Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-02 5:14 pm Purchase | 2026-05-26 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 3,850,385 5.500% | 1,231,790 (+47.04%) | Filing History |
| 2026-05-15 8:16 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management, LLC | 102,883 4.900% | 44,653 (+76.68%) | Filing History |
| 2026-05-15 5:23 pm Purchase | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 7,594,166 9.990% | 4,323,066 (+132.16%) | Filing History |
| 2026-05-15 09:13 am Unchanged | 2026-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Woodline Partners LP | 2,785,370 4.400% | 0 (Unchanged) | Filing History |
| 2026-04-29 06:41 am Unchanged | 2026-04-01 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Aberdeen Group plc | 75,000 4.160% | 0 (Unchanged) | Filing History |
| 2026-02-17 8:14 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management, LLC | 58,230 6.900% | 58,230 (New Position) | Filing History |
| 2026-02-17 3:20 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Woodline Partners LP | 2,785,370 9.500% | 2,785,370 (New Position) | Filing History |
| 2026-02-11 5:10 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 2,618,595 4.600% | 717,010 (+37.71%) | Filing History |
| 2026-02-06 5:28 pm Unchanged | 2026-01-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Ikarian Capital, LLC | 211,538 12.600% | 0 (Unchanged) | Filing History |
| 2026-02-02 8:01 pm Purchase | 2026-01-29 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 3,271,100 10.600% | 240,174 (+7.92%) | Filing History |
| 2026-01-28 11:05 am Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Aberdeen Group plc | 75,000 8.940% | 75,000 (New Position) | Filing History |
| 2025-12-16 4:04 pm Purchase | 2025-12-10 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Stonepine Capital Management LLC | 3,030,926 9.900% | 3,030,926 (New Position) | Filing History |
| 2025-12-15 9:53 pm Purchase | 2025-11-30 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Ikarian Capital, LLC | 211,538 25.200% | 211,538 (New Position) | Filing History |
| 2025-12-11 10:10 am Purchase | 2025-10-10 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Resolute Capital Asset Partners LLC | 50,000 8.500% | 50,000 (New Position) | Filing History |
| 2025-10-27 4:32 pm Purchase | 2025-10-20 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Integrated Core Strategies (US) LLC | 1,901,585 9.000% | 1,901,585 (New Position) | Filing History |
| 2025-05-15 3:40 pm Purchase | 2025-03-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Armistice Capital, LLC | 1,081,183 4.990% | 146,871 (+15.72%) | Filing History |
| 2025-02-14 4:54 pm Purchase | 2024-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | Armistice Capital, LLC | 934,312 9.990% | 934,312 (New Position) | Filing History |
| 2025-01-28 4:44 pm Purchase | 2025-01-27 | 13D | QUOIN PHARMACEUTICALS LTD SPON QNRX | Myers Michael | 939,230 4.900% | 316,657 (+50.86%) | Filing History |
| 2025-01-28 4:43 pm Purchase | 2025-01-27 | 13D | QUOIN PHARMACEUTICALS LTD SPON QNRX | Carter Denise P. | 939,238 4.900% | 316,825 (+50.90%) | Filing History |
| 2025-01-02 5:20 pm Purchase | 2024-12-23 | 13D | QUOIN PHARMACEUTICALS LTD SPON QNRX | Carter Denise P. | 622,413 6.900% | 622,413 (New Position) | Filing History |